AUG 31, 2017 12:38 PM PDT

Two Immune Cell Types Accidentally Promote Heart Disease

WRITTEN BY: Kara Marker

Prescribing drugs that lower “bad” cholesterol is a common approach to treating heart disease, but scientists from the Karolinska Institute think there may be another solution.

Histopathology of atherosclerosis. Credit: Wikimedia User Pathos

Atherosclerosis, a disease characterized by the development of plaques in blood vessels that impede blood flow, is a common marker of heart disease. Immune cells called T cells and dendritic cells are regular occupiers of atherosclerotic plaques, where a collection of these cells and other debris floating through blood vessels ultimately pack together and block the flow of oxygenated blood to the heart. By targeting these immune cells, Karolinska Institute scientists believe they could develop a method for treating heart disease completely separate from techniques focused on lowering low-density lipoprotein (LDL), AKA “bad” cholesterol.

The main “ingredient” of this new technique is a protein called PCSK9 (proprotein convertase subtilisin kexin 9). PCSK9 proteins degrade LDL receptors, which results in increased amounts of LDL. Thus, PCSK9 inhibitors are prescribed to lower LDL cholesterol. But there’s yet another use for PCSK9 inhibitors.

The scientists needed to find a way to inhibit immune cells promoting the formation of atherosclerotic plaques without suppressing the entire immune system. So, they needed to know what specifically activates the T cells and dendritic cells found in atherosclerotic plaques. They discovered two key players: PCSK9 and oxidized LDL.

When LDL becomes oxidized, a modification is made to the lipoprotein that promotes its interaction with and uptake by macrophages, making oxidized LDL a clear marker for cardiovascular disease.

Researchers collected T cells from carotid arteries from people with atherosclerosis and from healthy individuals. Dendritic cells were taken from human peripheral blood. They combined dendritic cells with oxidized LDL before adding in T cells.

They found that oxidized LDL both triggered production of PCSK9 proteins and induced dendritic cell maturation and T cell activation into helper cells. However, inhibiting PCSK9 reversed the effects.

“This changed a pro-inflammatory profile into an anti-inflammatory state that is potentially anti-atherosclerotic,” explained lead author Prof Johan Frostegård. “The benefits of PCSK9 inhibition extend beyond lowering LDL cholesterol.”

Source: Methods in Molecular Biology, European Society of Cardiology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 19, 2020
Cardiology
Common Biomarker Could Predict Heart Disease
JUL 19, 2020
Common Biomarker Could Predict Heart Disease
Heart failure is usually associated with conditions like high blood pressure and coronary artery disease. But there may ...
AUG 11, 2020
Cardiology
Investigating the Link Between a Kidney Protein and Hypertension
AUG 11, 2020
Investigating the Link Between a Kidney Protein and Hypertension
Hypertension, or high blood pressure, is a common cardiovascular condition with plenty of treatment options and preventi ...
SEP 10, 2020
Cardiology
Many Doctors Have Used the Wrong Criteria to Diagnose Hypertension
SEP 10, 2020
Many Doctors Have Used the Wrong Criteria to Diagnose Hypertension
A recent survey has shown that most health care professionals may not be using the current information to screen for and ...
SEP 16, 2020
Cardiology
Stem Cells Can Generate a 3D Mini-Model of the Heart
SEP 16, 2020
Stem Cells Can Generate a 3D Mini-Model of the Heart
The heart is a special organ, and while we know a lot about how it develops, there are still mysteries.
SEP 22, 2020
Cardiology
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
SEP 22, 2020
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
Cancer therapies have come quite far, with several options available for many cancers. An issue that has plagued many of ...
NOV 20, 2020
Neuroscience
The Link Between Sleep Apnea and Autoimmune Disease
NOV 20, 2020
The Link Between Sleep Apnea and Autoimmune Disease
Researchers from the University of Georgia have found more evidence for the link between obstructive sleep apnea (OSA) a ...
Loading Comments...